VBIO ▲ +4.8% - Valion Bio, Inc.
$VBIO - Valion Bio Advancing Entolimod into U.S. Government-Funded Therapeutic Efficacy Study Following Positive Safety Results
30-OCT-2026 07:50 AM ET
Share this post
More filings for $VBIO
VBIO ▼ -1.3% - Valion Bio, Inc.Oct 28, 2026VBIO ▲ +18.9% - Valion Bio, Inc.Oct 26, 2026VBIO ▲ +4.1% - Valion Bio, Inc.Oct 21, 2026VBIO ▼ -9.7% - Valion Bio, Inc.Oct 15, 2026VBIO ▲ +39.3% - Valion Bio, Inc.Oct 15, 2026VBIO ▼ -0.6% - Valion Bio, Inc.Oct 14, 2026
View full $VBIO filing history →💬 Comments
Loading comments…
Leave a comment